DATE/TIME: December 7, 9:45 – 10:00 AM
PRESENTATION TITLE: Representation of Minorities in Therapeutic Clinical Trials – a 15-Year Review of Lymphoma Cooperative Group Studies (Alliance A152123)
LOCATION: Room 6B | San Diego Convention Center
ABSTRACT #: 110
FIRST AUTHOR: Alvaro J. Alencar, MD

DATE/TIME: December 7, 2:30 – 2:45 PM
PRESENTATION TITLE: Genomic Determinants of Clinical Outcomes in Multiple Myeloma with t(11;14)(CCND1;IGH) Treated with Venetoclax
LOCATION: San Diego Ballroom AB | Marriott Marquis San Diego Marina
ABSTRACT #: 249
FIRST AUTHOR: Marcella Kaddoura, MD

DATE/TIME: December 7, 2:45 – 3:00 PM
PRESENTATION TITLE: Intrinsic Tumor Drivers and Immune Escape Mechanisms in CD19 CAR T-Cell Therapy Resistance for Aggressive Large B Cell Lymphoma
LOCATION: Pacific Ballroom Salons 15-17 | Marriott Marquis San Diego Marina
ABSTRACT #: 232
FIRST AUTHOR: Bachisio Ziccheddu

DATE/TIME: December 7, 4:00 – 4:15 PM
PRESENTATION TITLE: Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma
LOCATION: Marriott Grand Ballroom 11-13 | Marriott Marquis San Diego Marina
ABSTRACT #: 337
FIRST AUTHOR: Juan Pablo Alderuccio, MD
LAST AUTHOR: Craig H. Moskowitz, MD

DATE/TIME: December 8, 12:00 – 12:15 PM
PRESENTATION TITLE: Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort
LOCATION: Marriott Grand Ballroom 5-6 | Marriott Marquis San Diego Marina
ABSTRACT #: 571
FIRST AUTHOR: Juan Pablo Alderuccio, MD

DATE/TIME: December 8, 12:45 – 1:00 PM
PRESENTATION TITLE: Convergent Evolution Towards CD38 Biallelic Loss Is a Recurrent Mechanism of Resistance to Anti-CD38 Antibodies in Multiple Myeloma
LOCATION: San Diego Ballroom AB | Marriott Marquis San Diego Marina
ABSTRACT #: 592
FIRST AUTHOR: Benjamin Diamond, MD
LAST AUTHOR: Francesco Maura, MD

DATE/TIME: December 8, 1:00 – 1:15 PM
PRESENTATION TITLE: Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin
LOCATION: Ballroom 20CD | San Diego Convention Center
ABSTRACT #: 569
LAST AUTHOR: Craig H. Moskowitz, MD

DATE/TIME: December 8, 5:15 – 5:30 PM
PRESENTATION TITLE: Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitor INCB057643 in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study
LOCATION: Grand Hall D | Manchester Grand Hyatt San Diego
ABSTRACT #: 658
FIRST AUTHOR: Justin M. Watts, MD

Reception

DATE/TIME: December 8, 8:00 PM
TITLE: Miami Nights, Sylvester’s reception during ASH
LOCATION: PENDRY SAN DIEGO (550 J St, San Diego, CA 92101)
RSVP: Sylvester.org/MiamiNights

DATE/TIME: December 9, 2:45 – 3:00 PM
PRESENTATION TITLE: Decoding the Pivotal Roles of BCL10 Activating Mutations in DLBCL Drug Resistance and Lymphomagenesis
LOCATION: Ballroom 20CD | San Diego Convention Center
ABSTRACT #: 829
FIRST AUTHOR: Caroline A. Coughlin, BS
PRESENTING AUTHOR: Dhanvantri Chahar, PhD
LAST AUTHOR: Jonathan H. Schatz, MD

DATE/TIME: December 9, 3:00 – 3:15 PM
PRESENTATION TITLE: Tocilizumab Prophylaxis for Patients with Relapsed or Refractory Multiple Myeloma Treated with Teclistamab, Elranatamab or Talquetamab
LOCATION: San Diego Ballroom AB | Marriott Marquis San Diego Marina
ABSTRACT #: 932
FIRST AUTHOR: Andrew Kowalski, PharmD
LAST AUTHOR: C. Ola Landgren, MD, PhD

DATE/TIME: December 9, 4:30 – 4:45 PM
PRESENTATION TITLE: Sting and Vdac Inhibitors Ameliorate Ineffective Erythropoiesis in a Mouse Model of Anemia Induced By Mutation in EKLF/KLF1
LOCATION: Room 28 A-D | San Diego Convention Center
ABSTRACT #: 937
FIRST AUTHOR: Tasleem Arif, PhD

DATE/TIME: December 9, 5:00 – 5:15 PM
PRESENTATION TITLE: Venetoclax Plus Azacitidine for Newly Diagnosed Younger Acute Myeloid Leukemia Patients Independent of Fitness for Intensive Chemotherapy
LOCATION: Grand Hall B | Manchester Grand Hyatt San Diego
ABSTRACT #: 969
FIRST AUTHOR: Justin M. Watts, MD

DATE/TIME: December 9, 5:15 – 5:30 PM
PRESENTATION TITLE: Efficacy of Elranatamab (ELRA) in Combination with Carfilzomib (CFZ) and Dexamethasone (DEX) in the Phase 1b MagnetisMM-20 Trial in Relapsed or Refractory Multiple Myeloma (RRMM)
LOCATION: Hall B | San Diego Convention Center
ABSTRACT #: 1024
LAST AUTHOR: C. Ola Landgren, MD, PhD